AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
229,00 $ ↑6,18 (2,77%)
2026-06-05
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionThrive Wealth Management, LLC
Latest Disclosed Ownership5,963 shares
Latest Disclosed Value $ 1,296,941
Thrive Wealth Management, LLC reports 2.62% increase in ownership of 0QCV / AbbVie Inc.

On April 9, 2026 - Thrive Wealth Management, LLC filed a 13F-HR form disclosing ownership of 5,963 shares of AbbVie Inc. (GB:0QCV) valued at $1,291,109 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 5,811 shares of AbbVie Inc.. This represents a change in shares of 2.62% during the quarter. The current value of the position is $1,365,527 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F ABBVIE COM 00287Y109 5,963 152 2.62 1,297 -2.34 0.1933
2026-01-12 2025-12-31 13F ABBVIE COM 00287Y109 5,811 177 3.14 1,328 1.76 0.1951
2025-10-07 2025-09-30 13F ABBVIE COM 00287Y109 5,634 67 1.20 1,304 26.23 0.1968
2025-07-09 2025-06-30 13F ABBVIE COM 00287Y109 5,567 -413 -6.91 1,033 -17.49 0.1669
2025-04-10 2025-03-31 13F ABBVIE COM 00287Y109 5,980 -222 -3.58 1,253 13.61 0.2394
2025-01-16 2024-12-31 13F ABBVIE COM 00287Y109 6,202 42 0.68 1,102 -9.37 0.1982
2024-10-04 2024-09-30 13F ABBVIE COM 00287Y109 6,160 -7 -0.11 1,217 15.04 0.2232
2024-07-12 2024-06-30 13F ABBVIE COM 00287Y109 6,167 -196 -3.08 1,058 -8.72 0.2071
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 6,363 578 9.99 1,159 29.24 0.2394
2024-01-10 2023-12-31 13F ABBVIE COM 00287Y109 5,785 -331 -5.41 896 -1.65 0.1995
2023-10-13 2023-09-30 13F ABBVIE COM 00287Y109 6,116 544 9.76 912 21.47 0.2425
2023-07-12 2023-06-30 13F ABBVIE COM 00287Y109 5,572 1,034 22.79 751 3.73 0.1944
2023-04-07 2023-03-31 13F ABBVIE COM 00287Y109 4,538 76 1.70 723 0.28 0.1854
2023-01-25 2022-12-31 13F ABBVIE COM 00287Y109 4,462 965 27.60 721 53.73 0.2066
2022-10-24 2022-09-30 13F ABBVIE COM 00287Y109 3,497 106 3.13 469 -9.63 0.1643
2022-07-11 2022-06-30 13F ABBVIE COM 00287Y109 3,391 318 10.35 519 4.22 0.1810
2022-05-02 2022-03-31 13F ABBVIE COM 00287Y109 3,073 723 30.77 498 56.60 0.1473
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 2,350 2,350 318 0.1087
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.